Abstract
Immune response (Ir) gene(s) at the I-A subregion of the mouse H-2 complex influence susceptibility to experimental autoimmune myasthenia gravis (EAMG). To determine the importance of the Ir gene product, the Ia antigens, in EAMG pathogenesis, we studied the degree of EAMG susceptibility of an I-A mutant strain, the B6.C-H-2 bm12 (bm12), and its parent B6/Kh. According to the cellular, humoral, biochemical, and clinical manifestations of EAMG, the I-A mutation converted an EAMG susceptible strain (B6/Kh) into a relatively resistant strain (bm12). The relative resistance to EAMG induction in bm12 may be due to the lack of Ia.8 and/or la.39 determinants and/or quantitative expression of la antigens.
Similar content being viewed by others
Abbreviations
- MG:
-
myasthenia gravis
- AChR:
-
acetylcholine receptors
- EAMG:
-
experimental autoimmune myasthenia gravis
- Ir:
-
immune response
- B6:
-
C57BL/6J
- bm12 :
-
B6.C-H-2 bm12
- CFA:
-
complete Freund's adjuvant
- LNC:
-
lymph node cells
- PPD:
-
purified protein derivative
References
Berman, P. W. and Patrick, J.: Linkage between the frequency of muscle weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis. J. Exp. Med. 152: 507–520, 1980
Christadoss, P., Lennon, V. A., and David, C. S.: Genetic control of experimental autoimmune myasthenia gravis in mice. I. Lymphocyte proliferative response to acetylcholine receptor is under H-2 linked Ir gene control. J. Immunol. 123: 2540–2543, 1979
Christadoss, P., Lennon, V. A., Krco, C. J., Lambert, E. H., and David, C. S.: Genetic control of autoimmunity to acetylcholine receptors: Role of Ia molecules. Ann. NY Acad. Sci. 377: 258–276, 1981a
Christadoss, P., Krco, C.J., Lennon, V.A., and David, C.S.: Genetic control of experimental autoimmune myasthenia gravis in mice. II. Lymphocyte proliferative response to acetylcholine receptor is dependent on Lyt-1+23− cells. J. Immunol. 126: 1646–1647, 1981b
Christadoss, P., Lennon, V. A., Krco, C. J., and David, C. S.: Genetic control of experimental autoimmune myasthenia gravis in mice. III. la molecules mediate cellular immune responsiveness to acetylcholine receptors. J. Immunol. 128: 1141–1144, 1982
Christadoss, P., Lindstrom, J., and Talal, N.: Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: Inhibition with monoclonal anti-I-A antibodies. Cell. Immunol. 81: 1–8, 1983a
Christadoss, P., Dauphinee, M. J., Lindstrom, J., Dang, H., Fernandes, G., and Talal, N.: Deficient T cell mitogen response in murine experimental autoimmune myasthenia gravis: A defect in the adherent cell population. Cell Immunol. 79: 358–366, 1983b
Christadoss, P., Lindstrom, J., Munro, S., and Talal, N.: Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: Correlated with cellular, humoral and clinical responses. J. Neuroimmunol., in press, 1984
Drachman, D.: The biology of myasthenia gravis. Annu. Rev. Neurosci. 4: 195–225, 1981
Engel, A.: Myasthemia gravis. In P. Vinken and G. Bruyn (eds.): Handbook of Clinical Neurology, Part II, pp. 95–145, 1979
Fambrough, C. M., Drachman, D. B., and Satyamurti, D. S.: Neuromuscular junction in myasthenia gravis: Decreased acetylcholine receptors. Science 182: 293–295, 1973
Fathman, C. G., Kimoto, M., Melvold, R., and David, C. S.: Reconstitution Ir genes, la antigens and determinants by gene complementation. Proc. Natl. Acad. Sci. U.S.A. 78: 1853–1857, 1981
Goyert, S. M. and Silver, J: Further characterization of HLA-DS molecules: Implication for studies assessing the role of human la molecules in cell interactions and disease susceptibility. Proc. Natl. Acad. Sci. U.S.A. 80: 5719–5723, 1983
Hansen, T. H., Melvold, R. W., Arn, J. S., and Sachs, D. H.: Evidence for mutation in an I-A gene. Nature 285: 340–341, 1980
Huber, B., Hansen, T. H., and Thorley-Lawson, D. A.: Definition of Ia. W39 as a specific Ir gene product. Fed. Proc. 40: 960, 1981
Krco, C.J., Kazim, D.L., Atassi, M.Z., Melvold, R., and David, C.S.: Genetic control of immune response to hemoglobulin. III. Variant Aβ (bm12) but not Ae la polypeptide alters immune reactivity towards the a subunit of human hemoglobin. J. Immunogenet. 8: 471–476, 1981
Lafuse, W. P., Melvold, R. W., and David, C. S.: Serological and biochemical analysis of la molecules in the I-A mutant B6.C-H-2bm12. Transplantation 31: 434–438, 1981
Latarte, M., Teh, H., and Meghji, G.: Increased expression of la and Thy-1 antigens on mitogenactivated murine spleen lymphocytes. J. Immunol. 125: 370–377, 1980
Lin, C. S., Rosenthal, A. S., Blake, J. T., Passmore, H. C., and Hansen, T. H.: Selective deletion of an antigen specific Ir gene function in the I-A mutant B6.C-H-2bm12 is an antigen-presenting cell defect. Proc. Natl. Acad. Sci. U.S.A. 78: 6404–6410, 1983
Lindstrom, J.: Autoimmune response to acetylcholine receptors in myasthenia gravis and its animal model. Adv. Immunol. 27: 1–50, 1979
Lindstrom, J. M., Einarson, B., Lennon, V. A., and Seybold, M.: Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngenic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental autoimmune myasthenia gravis. J. Exp. Med. 144: 726–738, 1976
Lindstrom, J., Einarson, B., and Tzartos, S.: Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 74: 342–360, 1981
McKean, D. J., Melvold, R. W., and David, C. S.: Tryptic peptide comparison of la antigen α and β polypeptide from the I-A mutant B6-C-H-2bm12 and its congenic parental strain B6. Immunogenetics 14: 41–51, 1981
McKenzie, I. F. C., Morgan, G. M., Sandrin, M. S., Michaelides, M. M., Melvold, R. W., and Kohn, H. I.: B6.C-H-2bm12, a new H-2 mutation in the I region in the mouse. J. Exp. Med. 150: 1323–1338, 1979
Melvold, R. W. and Kohn, H. I.: Eight new histocompatibility mutations associated with the H-2 complex. Immunogenetics 3: 185–191, 1976
Michaelides, M., Sandrin, M., Morgan, G., McKenzie, I. F. C., Ashman, R., and Melvold, R. W.: Ir gene function in an I-A subregion mutant B6.C-H-2bm12. J. Exp. Med. 153: 464–469, 1981
Safwenberg, J., Hammarstrom, L., Lindblom, J. B., Matell, G., Moller, E., Osterman, P. O., and Smith, S. I. E.: HLA-A, -B, -C, and -D antigens in male patients with myasthenia gravis. Tissue Antigens 12: 136–142, 1978
Yoshida, T., Tsuchiya, M., Ono, A., Yoshimatsu, H., Satoyoshi, E., and Tsuji, K.: HLA antigens and myasthenia gravis in Japan. J. Neurol. Sci. 32: 195–201, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Christadoss, P., Lindstrom, J.M., Melvold, R.W. et al. Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis. Immunogenetics 21, 33–38 (1985). https://doi.org/10.1007/BF00372239
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00372239